The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease
- PMID: 18042241
- DOI: 10.1111/j.1468-1331.2007.01998.x
The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease
Abstract
Sleep disturbances in Parkinson's disease (PD) are a common problem. The aim of this study was to detail the frequency and nature of sleep disorders in a representative population of PD patients. A recently identified prevalent population, consisting of 161 PD patients were used as a representative population. Twenty-seven of 122 (22%) patients were identified as having marked sleep disorders, with sleep fragmentation and nocturia being the most commonly reported problems. Sleep scores worsened with higher Hoehn and Yahr stages. Sleep disturbances are a relatively common complication of PD and worsen with increasing Hoehn and Yahr stage.
Similar articles
-
Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients.Pain Pract. 2018 Jan;18(1):29-37. doi: 10.1111/papr.12578. Epub 2017 May 5. Pain Pract. 2018. PMID: 28371220
-
Sleep disturbances in Japanese patients with Parkinson's disease--comparing with patients in the UK.J Neurol Sci. 2005 Jul 15;234(1-2):73-8. doi: 10.1016/j.jns.2005.03.036. J Neurol Sci. 2005. PMID: 15944137
-
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.J Neurol Sci. 2009 Dec 15;287(1-2):200-4. doi: 10.1016/j.jns.2009.07.026. Epub 2009 Aug 22. J Neurol Sci. 2009. PMID: 19700173
-
Parkinson's disease and sleep/wake disturbances.Curr Neurol Neurosci Rep. 2015 Mar;15(3):8. doi: 10.1007/s11910-015-0525-5. Curr Neurol Neurosci Rep. 2015. PMID: 25687697 Review.
-
[Pathophysiology, clinical aspects and therapy of sleep disorders in Parkinson disease].Nervenarzt. 2001 Jun;72(6):416-24. doi: 10.1007/s001150050773. Nervenarzt. 2001. PMID: 11433700 Review. German.
Cited by
-
Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions.Int J Mol Sci. 2020 Aug 28;21(17):6235. doi: 10.3390/ijms21176235. Int J Mol Sci. 2020. PMID: 32872273 Free PMC article. Review.
-
Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson's disease.Front Aging Neurosci. 2022 Aug 22;14:889257. doi: 10.3389/fnagi.2022.889257. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36072482 Free PMC article.
-
Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.JAMA Neurol. 2014 Apr;71(4):463-9. doi: 10.1001/jamaneurol.2013.6239. JAMA Neurol. 2014. PMID: 24566763 Free PMC article.
-
Circadian and sleep disorders in Parkinson's disease.Exp Neurol. 2013 May;243:45-56. doi: 10.1016/j.expneurol.2012.08.018. Epub 2012 Aug 23. Exp Neurol. 2013. PMID: 22935723 Free PMC article. Review.
-
Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?NPJ Parkinsons Dis. 2017 Sep 5;3:28. doi: 10.1038/s41531-017-0030-4. eCollection 2017. NPJ Parkinsons Dis. 2017. PMID: 28890931 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical